HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$28.14
Day range
$27.90 - $28.59
Year range
$5.21 - $70.13
Market cap
140.51M USD
Avg Volume
170.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 11.01M | -12.61% |
Operating expense | 6.30M | -36.10% |
Net income | -7.54M | 34.40% |
Net profit margin | -68.53 | 24.93% |
Earnings per share | -1.47 | 34.53% |
EBITDA | -7.39M | 36.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.39M | -63.66% |
Total assets | 62.69M | -63.02% |
Total liabilities | 122.22M | -27.46% |
Total equity | -59.54M | — |
Shares outstanding | 5.00M | — |
Price to book | -2.36 | — |
Return on assets | -25.38% | — |
Return on capital | 41.64% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.54M | 34.40% |
Cash from operations | -3.19M | 62.78% |
Cash from investing | 372.00K | -98.69% |
Cash from financing | -17.76M | -77,121.74% |
Net change in cash | -20.58M | -203.58% |
Free cash flow | -1.85M | -77,826.32% |
About
Founded
2001
Website
Employees
102
